Creo Medical Group PLC Result of AGM (9621Z)
December 20 2017 - 7:32AM
UK Regulatory
TIDMCREO
RNS Number : 9621Z
Creo Medical Group PLC
20 December 2017
Creo Medical Group plc
("Creo" or "the Company")
Results of Annual General Meeting
Chepstow, South Wales - 20 December 2017 - Creo Medical Group
plc (AIM: CREO), a medical device company focused on the emerging
field of surgical endoscopy, today announces that all resolutions
put to its shareholders at the Company's Annual General Meeting
held earlier today in Chepstow were duly passed.
Contacts
Creo Medical: Cenkos: FTI Consulting:
Richard Rees Camilla Hume/Mark Brett Pollard
+44 (0)129 160 Connelly (NOMAD) / Mo Noonan
6005 richard.rees@creomedical.com Michael Johnson +44 (0)203 727
/ Russell Kerr (Sales) 1000
+44 (0)207 397 8900 creo@fticonsulting.com
About Creo Medical
Creo Medical, founded in 2003, is a medical device company
focused on the development and commercialisation of minimally
invasive surgical devices, by bringing advanced energy to
endoscopy. The Company's mission is to improve patient outcomes by
applying microwave and radiowave energy to surgical endoscopy. Creo
has developed CROMA, an electrosurgical platform that combines
bipolar radiofrequency for precise localised cutting and microwave
for controlled coagulation. This technology provides physicians
with flexible, accurate and controlled surgical solutions.
The Company's strategy is to bring its CROMA platform to market
through a suite of medical devices which the Company has designed,
initially for the emerging field of GI therapeutic endoscopy, an
area with high unmet needs. The CROMA platform will be developed
further for bronchoscopy and laparoscopy procedures. The Company
believes its technology can impact the landscape of surgery and
endoscopy by providing safer, less-invasive and more cost-efficient
option of treatment.
For more information about Creo Medical please see our website,
www.creomedical.com.
For more information about Creo Medical please see our website,
www.creomedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGUROORBRAUUAA
(END) Dow Jones Newswires
December 20, 2017 08:32 ET (13:32 GMT)
Creo Medical (LSE:CREO)
Historical Stock Chart
From Apr 2024 to May 2024
Creo Medical (LSE:CREO)
Historical Stock Chart
From May 2023 to May 2024